NOI to Sole Source - Division for Global HIV & Tuberculosis International laboratory
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- NOI_00222
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- 8(a) Sole Source
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Atlanta, Georgia 30333, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services is seeking to procure HIV-1/HIV-2 Plus O EIA, Geenius HIV 1/2 Supplemental Assay plus controls, and HIV-1 Western Blot test kits. These test kits are required to strengthen rapid test quality assurance in the international countries being supported under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The key objectives are to report quality data, reduce costs, and prevent/correct any errors in testing. The test kits must meet high-level standards that have been used for several years in the laboratories of the International Laboratory Branch (ILB).
This procurement is set aside for an 8(a) sole source award. There is no information provided about potential incumbents or current contractors. The notice does not specify an award value or budget range, but indicates that these test kits are vital to maintain the integrity and quality of training panels, plasma samples, and testing outcomes of the HIV recency projects under PEPFAR. The due date for responses to this pre-solicitation notice is June 6, 2024.
Notice text
These tests will be used to strengthen rapid test quality assurance in the international countries being supported. It is important to report quality data, reduce costs, and prevent/correct any errors in testing. These test kist meet high level standards that have been used for several years in the laboratories of ILB. Quality control checks occur for every lot using known samples to validate the accuracy of these test kits. Surveillance data from this can be used to rapidly detect and characterize HIV infection to inform a timely and targeted public health response to help reach the goals of the President’s Emergency Plan for AIDS Relief (PEPFAR).
These test kits include HIV-1/HIV-2 Plus O EIA, Geenius HIV 1/2 Supplemental Assay plus controls, and HIV-1 Western Blot. These requirements are set by the HIV serology team at DGHT/ILB serology and incidence laboratory and also the President’s Emergency Plan for AIDS Relief (PEPFAR) funded labs who participate in the HIV serology projects. In order to maintain the quality of testing and data the same supplies/reagents are required at all labs. This is vital to maintain the integrity and quality of training panels, plasma samples, and testing outcomes of the HIV recency projects.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Notice of intent to sole source BIORAD Test Kits | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity